Cleared Traditional

K823421 - PHADEBAS HUMYLASE CONTROL(H)

K823421 is an FDA 510(k) clearance for PHADEBAS HUMYLASE CONTROL(H), manufactured by Pharmacia, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 138-day FDA review.

K823421 · Pharmacia, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1983
Decision
138d
Days
Class 1
Risk

K823421 is an FDA 510(k) clearance for the PHADEBAS HUMYLASE CONTROL(H). Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Pharmacia, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 5, 1983 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Pharmacia, Inc. devices

FDA 510(k) Submission Details - K823421

510(k) Number K823421 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 1982
Decision Date April 05, 1983
Days to Decision 138 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 88d · This submission: 138d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 445
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K823421.
TRI-LEVEL BILIRUBIN CONTROLS
K833898 · Sandare Chemical Co., Inc. · Jan 1984
CHEM TRAK LIQUID BILIRUBIN CONTROL
K833097 · Medical Analysis Systems, Inc. · Jan 1984
SPINAL FLUID TOTAL PROTEIN CONTROL
K831527 · Quantimetrix Corp. · Jul 1983
DAC-CEL DIAGNATAL HCG STANDARDS RD49
K830204 · Wellcome Diagnostics · Feb 1983
BIO INTERFERENCE BLANKING MATERIAL
K823687 · American Monitor Corp. · Jan 1983
HUMAN PLASMA CONTROL FOR CEA-ROCHE
K822219 · Hoffmann-La Roche, Inc. · Dec 1982